These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 39387591)
1. Investigation of Zhang M; Yin Z; Chen B; Yu Z; Liang J; Tian X; Li D; Deng X; Peng L Microbiol Spectr; 2024 Nov; 12(11):e0425423. PubMed ID: 39387591 [TBL] [Abstract][Full Text] [Related]
2. Analyses of a Ceftazidime-Avibactam-Resistant Castanheira M; Arends SJR; Davis AP; Woosley LN; Bhalodi AA; MacVane SH mSphere; 2018 Sep; 3(5):. PubMed ID: 30258039 [TBL] [Abstract][Full Text] [Related]
3. Multidrug-resistant Citrobacter freundii ST139 co-producing NDM-1 and CMY-152 from China. Yang L; Li P; Liang B; Hu X; Li J; Xie J; Yang C; Hao R; Wang L; Jia L; Li P; Qiu S; Song H Sci Rep; 2018 Jul; 8(1):10653. PubMed ID: 30006537 [TBL] [Abstract][Full Text] [Related]
4. Emergence of a clinical Salmonella enterica serovar 1,4,[5], 12: i:-isolate, ST3606, in China with susceptibility decrease to ceftazidime-avibactam carrying a novel bla Wei J; Shen S; Zhang Q; Lu J; Mao S; Zou C; Zhou H; Wei Y; Ou X; Huang J; Wang D; Li X; Wan Q; Shan B; Zhang Z Eur J Clin Microbiol Infect Dis; 2024 May; 43(5):829-840. PubMed ID: 38388738 [TBL] [Abstract][Full Text] [Related]
5. Dynamic evolution of ceftazidime-avibactam resistance from a single patient through the IncX3_NDM-5 plasmid transfer and bla Tang C; Shen S; Yang W; Shi Q; Ding L; Han R; Hu F Int J Antimicrob Agents; 2024 Aug; 64(2):107228. PubMed ID: 38823494 [TBL] [Abstract][Full Text] [Related]
6. Coexistence of NDM-1-producing Escherichia coli and Citrobacter freundii in the same patient. Zhu B; Ying C; Xu H; Ying J J Glob Antimicrob Resist; 2018 Dec; 15():79-81. PubMed ID: 29727717 [TBL] [Abstract][Full Text] [Related]
7. Use of WGS data for investigation of a long-term NDM-1-producing Citrobacter freundii outbreak and secondary in vivo spread of blaNDM-1 to Escherichia coli, Klebsiella pneumoniae and Klebsiella oxytoca. Hammerum AM; Hansen F; Nielsen HL; Jakobsen L; Stegger M; Andersen PS; Jensen P; Nielsen TK; Hansen LH; Hasman H; Fuglsang-Damgaard D J Antimicrob Chemother; 2016 Nov; 71(11):3117-3124. PubMed ID: 27494919 [TBL] [Abstract][Full Text] [Related]
8. Coexistence of a novel KPC-2-encoding MDR plasmid and an NDM-1-encoding pNDM-HN380-like plasmid in a clinical isolate of Citrobacter freundii. Feng J; Qiu Y; Yin Z; Chen W; Yang H; Yang W; Wang J; Gao Y; Zhou D J Antimicrob Chemother; 2015 Nov; 70(11):2987-91. PubMed ID: 26260129 [TBL] [Abstract][Full Text] [Related]
9. Genomic characterization of a carbapenem-resistant Citrobacter freundii clinical isolate from China carrying bla Guo H; Li L; Zhang Y; He F J Glob Antimicrob Resist; 2024 Mar; 36():485-488. PubMed ID: 38007001 [TBL] [Abstract][Full Text] [Related]
10. Dissemination of Li X; Fu Y; Shen M; Huang D; Du X; Hu Q; Zhou Y; Wang D; Yu Y Antimicrob Resist Infect Control; 2018; 7():59. PubMed ID: 29713466 [TBL] [Abstract][Full Text] [Related]
11. Occurrence of multi-carbapenemase-producing Enterobacterales in a tertiary hospital in Madrid (Spain): A new epidemiologic scenario. Cabello M; Hernández-García M; Maruri-Aransolo A; Michelena M; Pérez-Viso B; Ponce-Alonso M; Cantón R; Ruiz-Garbajosa P J Glob Antimicrob Resist; 2024 Sep; 38():281-291. PubMed ID: 38996870 [TBL] [Abstract][Full Text] [Related]
12. Genetically unrelated multidrug- and carbapenem-resistant Citrobacter freundii detected in outpatients admitted to a Portuguese hospital. Santos C; Ramalheira E; Da Silva G; Mendo S J Glob Antimicrob Resist; 2017 Mar; 8():18-22. PubMed ID: 27915087 [TBL] [Abstract][Full Text] [Related]
13. Whole Genome Sequencing of a Dziri R; Kuşkucu MA; Arfaoui A; Fethi M; Ifaoui S; Bellaaj R; Ouzari I; Saltoğlu N; Klibi N Microb Drug Resist; 2022 Jan; 28(1):18-22. PubMed ID: 34348037 [No Abstract] [Full Text] [Related]
14. Emergence of a cefepime- and cefpirome-resistant Citrobacter freundii clinical isolate harbouring a novel chromosomally encoded AmpC beta-lactamase, CMY-37. Ahmed AM; Shimamoto T Int J Antimicrob Agents; 2008 Sep; 32(3):256-61. PubMed ID: 18619820 [TBL] [Abstract][Full Text] [Related]
15. Circulation of Venditti C; Fortini D; Villa L; Vulcano A; D'Arezzo S; Capone A; Petrosillo N; Nisii C; Carattoli A; Di Caro A Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559268 [TBL] [Abstract][Full Text] [Related]
16. Molecular characterization of carbapenem and ceftazidime-avibactam-resistant Enterobacterales and horizontal spread of Sobh G; Araj GF; Finianos M; Sourenian T; Hrabak J; Pappagianitsis CC; Chaar ME; Bitar I Front Cell Infect Microbiol; 2024; 14():1407246. PubMed ID: 38962322 [TBL] [Abstract][Full Text] [Related]
18. Complete-genome sequencing and comparative genomic characterization of bla Ye J; Jin L; Li Y; Xu H; Lin Y; Zhou T; Zheng B; Wang M; Wang Z BMC Genomics; 2023 Aug; 24(1):506. PubMed ID: 37649002 [TBL] [Abstract][Full Text] [Related]
19. Hospital sewage water: a reservoir for variants of New Delhi metallo-β-lactamase (NDM)- and extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae. Parvez S; Khan AU Int J Antimicrob Agents; 2018 Jan; 51(1):82-88. PubMed ID: 28887202 [TBL] [Abstract][Full Text] [Related]
20. Characterization of mobile genetic elements carrying VIM-1 and KPC-2 carbapenemases in Citrobacter freundii isolates in Madrid. Villa J; Arana DM; Viedma E; Perez-Montarelo D; Chaves F Int J Med Microbiol; 2017 Sep; 307(6):340-345. PubMed ID: 28711315 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]